Zvi Granot, PhD

The most abundant white blood cells in the human circulatory system are neutrophils, which guard against microbial infections and participate in events of inflammation. In cancer, they can kill tumor cells and limit disease progression. But their cancer-fighting power is often limited by factors generated by the tumor. The Granot lab is assessing the potential of a novel drug-delivery platform that modifies neutrophils, helping them function even in the presence of these factors, limiting tumor growth and progression.

View Grant Recipient Profile